Ria J.J. Poort-Keesom

Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer

Jurgen M.J. Piek, P. J. van Diest, Ronald P. Zweemer et al. · The Journal of Pathology · 2001 · 774 citations

MUC1 (EMA) is preferentially expressed by ALK positive anaplastic large cell lymphoma, in the normally glycosylated or only partly hypoglycosylated form

Rosita L. ten Berge, Frank G.M. Snijdewint, Silvia von Mensdorff‐Pouilly et al. · Journal of Clinical Pathology · 2001 · 48 citations

Characterization of a New MUC1 Monoclonal Antibody (VU-2-G7) Directed to the Glycosylated PDTR Sequence of MUC1

Kanji Ryuko, Dick J. Schol, Frank G.M. Snijdewint et al. · Tumor Biology · 2000 · 30 citations

T cell infiltration and MHC I and II expression in the presence of tumor antigens: An immunohistochemical study in patients with serous epithelial ovarian cancer

Hans W. Nijman, P J van Diest, Ria J.J. Poort-Keesom et al. · European Journal of Obstetrics & Gynecology and Reproductive Biology · 2001 · 22 citations · Full text

Cancer Immunosurveillance, T-regulatory Cell, Immunology +9

Influence of chemotherapy on the expression of p53, HER-2/neu and proliferation markers in ovarian cancer

Hans W. Nijman, Peter Kenemans, Ria J.J. Poort-Keesom et al. · European Journal of Obstetrics & Gynecology and Reproductive Biology · 1999 · 19 citations · Full text

Proliferation Markers, Medicine, Gynecology +8